Nymox Pharmaceutical
NYMX
#10362
Rank
C$25.45 M
Marketcap
Country
C$0.28
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -C$2.93 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -C$9.11 Million, an increase over its 2021 earnings that were of -C$17.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$2.93 Million-67.91%
2022 -C$9.11 Million-47.71%
2021 -C$17.41 Million6.61%
2020 -C$16.33 Million-10.91%
2019 -C$18.33 Million24.24%
2018 -C$14.75 Million-20.03%
2017 -C$18.45 Million2.71%
2016 -C$17.96 Million-63.86%
2015 -C$49.7 Million674.44%
2014 -C$6.42 Million-6.11%
2013 -C$6.84 Million-35.66%
2012 -C$10.63 Million-20.76%
2011 -C$13.41 Million38.33%
2010 -C$9.7 Million35.59%
2009 -C$7.15 Million11.8%
2008 -C$6.4 Million-12.94%
2007 -C$7.35 Million8.85%
2006 -C$6.75 Million36.5%
2005 -C$4.95 Million-4.4%
2004 -C$5.18 Million-14.58%
2003 -C$6.06 Million
2001 -C$4.45 Million-20.54%
2000 -C$5.59 Million21.72%
1999 -C$4.6 Million-25.56%
1998 -C$6.17 Million101.3%
1997 -C$3.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.23 B-1,202,274.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.77 B-490,197.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.34 B-376,638.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.40 B-1,440,405.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$1.91 B-63,774.22%๐Ÿ‡บ๐Ÿ‡ธ USA